Neuland Laboratories EV/EBITDA
What is the EV/EBITDA of Neuland Laboratories?
The EV/EBITDA of Neuland Laboratories Limited is 21.69
What is the definition of EV/EBITDA?
EV/EBITDA is enterprise value divided by earnings before interest, tax, depreciation, and amortization. It is a measure of how expensive a stock is and is more frequently valid for comparisons across companies than the price to earnings ratio. It measures the price (in the form of enterprise value) an investor pays for the benefit of the company’s cash flow (in the form of EBITDA).
= enterprise value / EBITDA
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA of companies in the Health Care sector on BSE compared to Neuland Laboratories
What does Neuland Laboratories do?
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, antiemetic, central nervous system, fluoroquinolones, corticosteroids, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was founded in 1984 and is headquartered in Hyderabad, India.
Companies with ev/ebitda similar to Neuland Laboratories
- Life Storage Inc has EV/EBITDA of 21.65
- Invitation Homes Inc has EV/EBITDA of 21.67
- Extra Space Storage has EV/EBITDA of 21.67
- Paramount Communications has EV/EBITDA of 21.68
- Surana Solar has EV/EBITDA of 21.68
- Tungsten plc has EV/EBITDA of 21.69
- Neuland Laboratories has EV/EBITDA of 21.69
- Chesapeake has EV/EBITDA of 21.69
- Edenred SA has EV/EBITDA of 21.70
- Henderson Land Development has EV/EBITDA of 21.70
- Dow Inc has EV/EBITDA of 21.71
- Yum China Inc has EV/EBITDA of 21.71
- Hindustan Composites has EV/EBITDA of 21.71